This document discusses nitric oxide (NO) research presented by Nathan Bryan, Chief Science Officer of Neogenis Labs. It summarizes that NO is an important signaling molecule in the body that plays roles in many physiological systems. However, the body's natural production of NO declines with age. The document proposes strategies for restoring NO levels through dietary sources of nitrates and nitrites, herbal extracts, and supplemental NO donors to promote cardiovascular and overall health. Clinical trials on a supplemental lozenge product showed increased plasma NO markers and benefits such as reduced triglycerides and blood pressure.